Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma [Phase 1]
The document reports the completion of a Phase 1 trial of AMG-479 in patients with advanced solid tumors and Non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 1]
A Phase 1 trial evaluating the safety and feasibility of combining estramustine, docetaxel, and carboplatin in men with prostate cancer that…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms [Phase 2, Phase 3]
Clinical trial update reporting results for Symbiotic in reducing acute radiation proctitis symptoms in patients with radiation proctitis an…
-
CLINICAL_TRIALS trial_result · 2013-07-17Clinical Trial Update: Preoperative Radiation Therapy for High Risk Prostate Cancer [Phase 1]
This report provides an update on a Phase 1 study evaluating preoperative radiation therapy for high-risk prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 2]
This update reports the results of SWOG S0032, a Phase 2 trial evaluating combination chemotherapy plus hormone therapy in metastatic prosta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Evaluate Recovery of Testosterone for Patients Using Eligard [Phase 4]
Phase 4 clinical trial evaluating recovery of testosterone in patients using Eligard for prostate cancer has completed with results posted i…
-
CLINICAL_TRIALS withdrawal · 2013-07-15Clinical Trial Update: Periperal Blood Lymphocytes During Prostate RT
A clinical trial investigating peripheral blood lymphocytes during prostate radiotherapy has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating zoledronic acid to prevent bone loss in men with prostate cancer undergoing androgen deprivation therapy has comple…
-
CLINICAL_TRIALS research · 2013-07-11Clinical Trial Update: Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer
A prospective observational study evaluating insulin sensitivity during and after GnRH agonist therapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function [Phase 4]
Phase 4 trial comparing combined general/epidural anesthesia versus general anesthesia alone on diaphragmatic function in prostate cancer pa…
-
CLINICAL_TRIALS research · 2013-07-11Clinical Trial Update: R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]
A Phase 2 clinical trial evaluating tipifarnib (R115777) for progressive, metastatic prostate cancer that has not responded to hormone thera…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors [Phase 2]
Phase 2 clinical trial evaluating a lifestyle intervention to improve insulin sensitivity and cardiovascular risk markers in prostate cancer…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer
A completed prospective study assessing insulin resistance and cardiovascular disease risk in men undergoing androgen deprivation therapy fo…
-
CLINICAL_TRIALS trial_result · 2013-07-11Clinical Trial Update: The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer [NA]
This completed clinical trial, sponsored by Sunnybrook Health Sciences Centre, assessed the value of MultiSpectral 3 Tesla MRI in active sur…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer [Phase 1]
Phase 1 clinical trial update on High-Intensity Focused Ultrasound to treat locally recurrent prostate cancer.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate [Phase 1]
A Phase 1 trial evaluating ultrasound-based treatment for prostate cancer confined to the prostate has completed.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer [Phase 2]
A Phase 2 trial evaluating paclitaxel, topotecan, and estramustine for metastatic hormone-refractory prostate cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer [Phase 2]
A Phase 2 trial of antineoplaston therapy for stage III or stage IV prostate cancer was withdrawn, according to the trial update.
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: An Open Label Prostate Cancer Study in Japanese Patients [Phase 1]
An open-label Phase 1 trial of a prostate cancer therapy in Japanese patients, sponsored by AstraZeneca, has completed.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer [Phase 2]
Phase 2 trial evaluating samarium-153-EDTMP with or without PSA/TRICOM vaccine in men with androgen-insensitive (castration-resistant) prost…
-
FDA label_change · 2013-06-26FDA Approved: DOCETAXEL — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for docetaxel, resulting in changes to the product labeling. The changes may include updates to indi…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer [Phase 3]
A Phase 3 trial evaluating a combination of dexamethasone, aspirin, and diethylstilbestrol for locally advanced or metastatic prostate cance…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Diet and PSA Levels in Patients With Prostate Cancer [Phase 3]
A Phase 3 clinical trial evaluating the impact of diet on PSA levels in men with prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer [Phase 3]
A Phase 3 trial evaluating docetaxel plus prednisone for hormone-refractory metastatic prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Lycopene In Preventing of Prostate Cancer [Phase 1]
A Phase 1 trial investigating lycopene for the prevention of prostate cancer has completed.